Sidransky David
| Company | Stock Code | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|---|
| Ascentage-B | 06855 | 31-Mar-21 | 02-Jan-25 | MbNC | Re-designated as the chairman of the Nomination Committee to comply with the listing rules of The Nasdaq Stock Market LLC. | |
| Ascentage Pharma Group International | 06855 | 31-Mar-21 | 01-Mar-19 | INED |